ExeGi Pharma's Launch of Visbiome Vet GI Care+ Revolutionizes Pet Health in Canada
ExeGi Pharma Introduces Visbiome Vet GI Care+ in Canada
ExeGi Pharma LLC is making a significant impact in the world of pet health with the introduction of Visbiome Vet GI Care+ in Canada. This high-potency probiotic is now available to veterinarians and pet owners, promising immense benefits for pets suffering from gastrointestinal issues.
A Game Changer for Pet Health
Launched on November 18, 2025, Visbiome Vet GI Care+ stands out in the market by delivering an impressive 112.5 billion live beneficial bacteria in each capsule. This unique formulation includes the De Simone Formulation, an eight-strain probiotic blend that has been proven effective in various clinical settings.
Dr. Caroline Mansfield, a respected veterinarian, highlighted the importance of a balanced gut microbiome for pets, which is crucial for their overall digestive health and immune function. She noted that the clinical data supporting the use of Visbiome Vet GI Care+ positions it as a valuable resource for veterinary specialists addressing complex gastrointestinal issues in animals.
Growing Demand in Canada
The demand for Visbiome Vet GI Care+ has been building for years, especially with increasing reliance on dietary solutions for pet gastrointestinal disorders. ExeGi Pharma's CEO, Marc Tewey, emphasized that Canadian veterinarians have long expressed a need for this product, and now it is finally available to meet those needs. This probiotic formulation showcases one of the highest concentrations of probiotics on the market, underpinned by comprehensive clinical research.
Clinical Backing and Expert Endorsements
Over the years, Visbiome Vet GI has gained traction through seven clinical studies published in peer-reviewed veterinary journals, proving its effectiveness. This focus on evidence-based veterinary health products is helping shift the paradigm towards more diet-oriented therapies for pets facing GI difficulties. Unlike many other veterinary probiotics, Visbiome Vet GI Care+ offers a tailored dosing strategy based on the pet's weight, ensuring optimal efficacy. Furthermore, to maintain maximum potency, these products are stored and shipped under cold conditions.
Availability and Future Prospects
Visbiome Vet GI Care+ will be accessible exclusively through veterinary clinics and pharmacies. Veterinarians can obtain the product from major veterinary wholesalers or directly through the website VisbiomeVet.ca. With this innovative solution emerging in Canada, ExeGi Pharma looks forward to enhancing the well-being of pets across the country.
About ExeGi Pharma and Visbiome
ExeGi Pharma LLC is a biotechnology company dedicated to developing and commercializing live biotherapeutic and probiotic solutions. The goal is to formulate effective treatments to alleviate serious health issues, allowing both humans and pets to lead healthier lives. Visbiome Vet, as part of their product line, focuses on optimizing the health of companion animals by supporting a healthy GI immune system.
Their products are built on rigorous scientific foundations, ensuring pet owners can be confident in the health outcomes they seek for their furry companions. As this new probiotic enters the Canadian market, pet health specialists are eager to explore its potential benefit, with expectations for strong adoption by both veterinary professionals and discerning pet owners.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.